Robert Wong

5.1k citations

78 papers · 3.7k indexed · 1 hit paper · h-index 30

Impact in

Rheumatology top 0.2%
- Spondyloarthritis Studies and Treatments
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
Hematology top 1%
- Autoimmune and Inflammatory Disorders Research

Papers in ⓘ

Hematology 29
- Autoimmune and Inflammatory Disorders Research 29
Rheumatology 38
- Spondyloarthritis Studies and Treatments 25
- Rheumatoid Arthritis Research and Therapies 20

Co-authors: H. Küpper (13 shared papers)Désirée van der Heijde (8 shared papers)Joachim Sieper (4 shared papers)John C. Davis (6 shared papers)Jürgen Braun (4 shared papers)Walter P. Maksymowych (6 shared papers)Michael Schiff (3 shared papers)Ben A. C. Dijkmans (2 shared papers)
Journals: Annals of the Rheumatic Diseases (13 papers)The Journal of Rheumatology (5 papers)Arthritis Research & Therapy (5 papers)Transplantation (5 papers)Lara D. Veeken (4 papers)
Partner nations: United States Germany Netherlands

In The Last Decade

Robert Wong

76 papers receiving 3.6k citations

Hit Papers

align trajectories log scale

Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double‐blind, placebo‐controlled trial 2006 · 660 citations

Peers

Countries citing papers authored by Robert Wong

Since Specialization

Citations

This map shows the geographic impact of Robert Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Wong more than expected).

Fields of papers citing papers by Robert Wong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Wong. The network helps show where Robert Wong may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert Wong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert Wong Line = papers co-authored together Robert Wong links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 78 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double‐blind, placebo‐controlled trial Arthritis & Rheumatism ·Désirée van der Heijde, Alan Kivitz, Michael Schiff, Joachim Sieper, Ben A. C. Dijkmans, Jürgen Braun, Maxime Dougados, John D. Reveille, Robert Wong, H. Küpper, John C. Davis Hit paper breakdown →	2006	660
2	Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years Arthritis Research & Therapy ·Désirée van der Heijde, David Salonen, Barbara N. Weissman, Robert Landewé, Walter P. Maksymowych, H. Küpper, Shaila Ballal, E Gibson, Robert Wong, (unknown)	2009	306
3	Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined sacroiliitis: Results of a twelve‐week randomized, double‐blind, placebo‐controlled trial followed by an open‐label extension up to week fifty‐two Arthritis & Rheumatism ·Hildrun Haibel, Martín Rudwaleit, Joachim Listing, F. Heldmann, Robert Wong, H. Küpper, Jürgen Braun, Joachim Sieper	2008	231
4	Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT) Annals of the Rheumatic Diseases ·Philip J. Mease, P A Ory, John T. Sharp, Christopher T. Ritchlin, Filip Van den Bosch, Frank R. Wellborne, C. Birbara, G. T. D. Thomson, Renee Perdok, J Medich, Robert Wong, Dafna D. Gladman	2008	214
5	Development and validation of the Spondyloarthritis Research Consortium of Canada (SPARCC) Enthesitis Index Annals of the Rheumatic Diseases ·Walter P. Maksymowych, Charlotte Mallon, Scott Morrow, Kam Shojania, Wojciech P. Olszynski, Robert Wong, John S. Sampalis, Barbara Conner‐Spady	2008	203
6	Adalimumab significantly reduces both spinal and sacroiliac joint inflammation in patients with ankylosing spondylitis: A multicenter, randomized, double‐blind, placebo‐controlled study Arthritis & Rheumatism ·R. Lambert, David Salonen, Proton Rahman, Robert D. Inman, Robert Wong, Steven Einstein, G. T. D. Thomson, André Beaulieu, D. Choquette, Walter P. Maksymowych	2007	198
7	Validity, reliability and responsiveness of the Work Productivity and Activity Impairment Questionnaire in ankylosing spondylitis Lara D. Veeken ·Margaret C. Reilly, Katherine Gooch, Robert Wong, H. Küpper, Désirée van der Heijde	2010	181
8	Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial Annals of the Rheumatic Diseases ·Désirée van der Heijde, Michael Schiff, Joachim Sieper, Alan Kivitz, Robert Wong, H. Küpper, Ben A. C. Dijkmans, Philip J. Mease, John C. Davis	2008	138
9	The Efficacy and Safety of Clazakizumab, an Anti–Interleukin‐6 Monoclonal Antibody, in a Phase IIb Study of Adults With Active Psoriatic Arthritis Arthritis & Rheumatology ·Philip J. Mease, Alice B. Gottlieb, Alberto Berman, Edit Drescher, Jun Xing, Robert Wong, Subhashis Banerjee	2016	122
10	The mechanisms of action of cyclosporin A in the treatment of psoriasis Immunology Today ·Robert Wong, Christine M. Winslow, Kevin D. Cooper	1993	97
11	A PHASE I STUDY OF A 4-WEEK COURSE OF SDZ-RAD (RAD) IN QUIESCENT CYCLOSPORINE-PREDNISONE-TREATED RENAL TRANSPLANT RECIPIENTS1,2 Transplantation ·Barry D. Kahan, Robert Wong, Kate Carter, Stephen H. Katz, Janet Von Fellenberg, Charles T. Van Buren, Silke Appel‐Dingemanse	1999	86
12	THE PHARMACOKINETICS OF A MICROEMULSION FORMULATION OF CYCLOSPORINE IN PRIMARY RENAL ALLOGRAFT RECIPIENTS1 Transplantation ·Gary W. Barone, Cheng Chang, Miles G. Choc, Jon B. Klein, Christopher L. Marsh, John A. Meligeni, David I. Min, Mark D. Pescovitz, Raymond Pollak, Timothy L. Pruett, James B. Stinson, John S. Thompson, Eva M. Vasquez, Thomas Waid, Duane G. Wombolt, Robert Wong	1996	82
13	Efficacy and safety of abatacept in active primary Sjögren's syndrome: results of a phase III, randomised, placebo-controlled trial Annals of the Rheumatic Diseases ·Alan N. Baer, Jacques‐Eric Gottenberg, E. William St. Clair, Takayuki Sumida, Tsutomu Takeuchi, Raphaèle Séror, Gary N. Foulks, Marleen Nys, Sumanta Mukherjee, Robert Wong, Neelanjana Ray, Hendrika Bootsma	2020	81
14	Temporal arteritis without an elevated erythrocyte sedimentation rate The American Journal of Medicine ·Robert Wong, Joseph H. Korn	1986	74
15	Health‐related quality of life outcomes in patients with active ankylosing spondylitis treated with adalimumab: Results from a randomized controlled study Arthritis Care & Research ·John C. Davis, Dennis A. Revicki, Désirée M. F. van der Heijde, Anne M. Rentz, Robert Wong, H. Küpper, Michelle P. Luo	2007	68
16	Physical function, disease activity, and health-related quality-of-life outcomes after 3 years of adalimumab treatment in patients with ankylosing spondylitis Arthritis Research & Therapy ·Désirée van der Heijde, Dennis A. Revicki, Katherine Gooch, Robert Wong, H. Küpper, Neesha Harnam, Chris Thompson, Joachim Sieper, (unknown)	2009	66
17	Adalimumab reduces pain, fatigue, and stiffness in patients with ankylosing spondylitis: results from the adalimumab trial evaluating long-term safety and efficacy for ankylosing spondylitis (ATLAS). PubMed ·Dennis A. Revicki, Michelle P. Luo, P Wordsworth, Robert Wong, Naijun Chen, John C. Davis	2008	62
18	Epidemiologic Health Study of Workers in an Aluminum Smelter in British Columbia American Review of Respiratory Disease ·Moira Chan‐Yeung, Robert Wong, L MacLean, Felisa Tan, Michael Schulzer, Donald A. Enarson, Alastair J. Martin, Ron Dennis, Stefan Grzybowski	1983	48
19	Adalimumab effectively reduces the signs and symptoms of active ankylosing spondylitis in patients with total spinal ankylosis Annals of the Rheumatic Diseases ·Désirée van der Heijde, Aileen L. Pangan, Michael Schiff, Jürgen Braun, M. Borofsky, José Carlos Sánchez de la Torre, John C. Davis, Robert Wong, H. Küpper, Eduardo Collantes‐Estévez	2007	47
20	A comparison of the specificity of the 1971 and 1982 American Rheumatism Association criteria for the classification of systemic lupus erythematosus Arthritis & Rheumatism ·Contance M. Passas, Robert Wong, Margaret G. E. Peterson, Marcia A. Testa, Naomi F. Rothfield	1985	47

About Robert Wong

Robert Wong is a scholar working on Hematology, Rheumatology, Transplantation, Speech and Hearing and Immunology, having authored 78 papers that have together received 3.7k indexed citations. Recurring topics across this work include Autoimmune and Inflammatory Disorders Research (29 papers), Spondyloarthritis Studies and Treatments (25 papers), Rheumatoid Arthritis Research and Therapies (20 papers), Psoriasis: Treatment and Pathogenesis (12 papers), Adolescent and Pediatric Healthcare (8 papers), Chronic Lymphocytic Leukemia Research (6 papers), Immunodeficiency and Autoimmune Disorders (6 papers) and Kawasaki Disease and Coronary Complications (5 papers). The work is most often cited by research in Rheumatology (2.6k citations), Hematology (1.0k citations), Transplantation (249 citations), Immunology (1.7k citations) and Orthopedics and Sports Medicine (244 citations). Robert Wong has collaborated with scholars based in United States, Germany and Netherlands. Frequent co-authors include H. Küpper, Désirée van der Heijde, Joachim Sieper, John C. Davis, Jürgen Braun, Walter P. Maksymowych, Michael Schiff, Ben A. C. Dijkmans, Alan Kivitz and Maxime Dougados. Their work appears in journals such as Annals of the Rheumatic Diseases, The Journal of Rheumatology, Arthritis Research & Therapy, Transplantation and Lara D. Veeken.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact